Desflurane differentially affects the release of proinflammatory cytokines in plasma and bronchoalveolar fluid of endotoxemic rats

International Journal of Molecular Medicine

Volumn 17, Issue 6, 2006, Pages 1139-1144

  Boost, Kim Alexander ^a   Hofstetter, Christian ^a   Flondor, Michael ^a   Betz, Christian ^a   Homann, Markus ^a   Pfeilschifter, Josef ^a   Muehl, Heiko ^a   Zwissler, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Desflurane; Interleukin 1 ; Lipopolysaccharide; Rat; Tumor necrosis factor

Indexed keywords

CYTOKINE; DESFLURANE; DRUG DERIVATIVE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOFLURANE; LIPOPOLYSACCHARIDE; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NITRITE;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; ENDOTOXEMIA; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; ENDOTOXEMIA; I-KAPPA B PROTEINS; ISOFLURANE; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745727516     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.6.1139     Document Type: Article

References (21)

1. Bhatia M and Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202: 145-156, 2004.
2. Giannoudis PV: Current concepts of the inflammatory response after major trauma: an update. Injury 34: 397-404, 2003.
3. Plachinta RV, Hayes JK, Cerilli LA and Rich GF: Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats. Anesthesiology 98: 89-95, 2003.
4. Helmy SA and Al-Attiyah RJ: The effect of halothane and isoflurane on plasma cytokine levels. Anaesthesia 55: 904-910, 2000.
5. Giraud O, Seince PF, Rolland C, Lecon-Malas V, Desmonts JM, Aubier M and Dehoux M: Halothane reduces the early lipopolysaccharide- induced lung inflammation in mechanically ventilated rats. Am J Respir Crit Care Med 162: 2278-2286, 2000. (Pubitemid 32051701)
6. Moudgil GC, Allan RB, Russell RJ and Wilkinson PC: Inhibition, by anaesthetic agents, of human leucocyte locomotion towards chemical attractants. Br J Anaesth 49: 97-105, 1977.
7. Mitsuhata H, Shimizu R and Yokoyama MM: Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 17: 529-534, 1995.
8. Hofstetter C, Flondor M, Boost KA, Koehler P, Pfeilschifter J, Zwissler B and Muehl H: A brief exposure to isoflurane (50 seconds) markedly impacts on plasma cytokine levels in endotoxemic rats. Int Immunopharm 5: 1519-1522, 2005. (Pubitemid 40967909)
9. Strunk V, Hahnenkamp K, Schneuing M, Fischer LG and Rich GF: Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation. Anesth Analg 92: 681-687, 2001. (Pubitemid 32185112)
10. Taniguchi T, Shibata K and Yamamoto K: Ketamine inhibits endotoxin-induced shock in rats. Anesthesiology 95: 928-932, 2001.
11. Weigand MA, Horner C, Bardenheuer HJ and Bouchon A: The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol 18: 455-475, 2004.
12. Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.
13. Siler TM, Swierkosz JE, Hyers TM, Fowler AA and Webster RO: Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome. Exp Lung Res 15: 881-894, 1989.
14. Aldridge AJ: Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg 168: 204-214, 2002. (Pubitemid 34879391)
15. Molloy RG, Mannick JA and Rodrick ML: Cytokines, sepsis and immunomodulation. Br J Surg 80: 289-297, 1993.
16. Giraud O, Molliex S, Rolland C, Lecon-Malas V, Desmonts JM, Aubier M and Dehoux M: Halogenated anesthetics reduce interleukin-1beta-induced cytokine secretion by rat alveolar type II cells in primary culture. Anesthesiology 98: 74-81, 2003.
17. Zhang G and Ghosh S: Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res 6: 453-457, 2000.
18. De Rossi LW, Brueckmann M, Rex S, Barderschneider M, Buhre W and Rossaint R: Xenon and isoflurane differentially modulate lipopolysaccharide-induced activation of the nuclear transcription factor KB and production of tumor necrosis factor-alpha and interleukin-6 in monocytes. Anesth Analg 98: 1007-1012, 2004. (Pubitemid 38405411)
19. Tschaikowsky K, Ritter J, Schroppel K and Kuhn M: Volatile anesthetics differentially affect immunostimulated expression of inducible nitric oxide synthase: role of intracellular calcium. Anesthesiology 92: 1093-1102, 2000.
20. Thomassen MJ, Buhrow LT, Connors MJ, Kaneko FT, Erzurum SC and Kavuru MS: Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 17: 279-283, 1997.
21. Kunz D, Walker G and Pfeilschifter J: Dexamethasone differentially affects interleukin 1β and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Biochem J 304: 3337-3340, 1994.